New Zealand markets open in 6 hours 18 minutes

Weihai Baihe Biology Technological Co., Ltd. (603102.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
36.28-0.35 (-0.96%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.34B
Enterprise value 1.26B
Trailing P/E 14.77
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.84
Price/book (mrq)1.51
Enterprise value/revenue 1.52
Enterprise value/EBITDA 6.91

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-16.67%
S&P500 52-week change 325.38%
52-week high 348.98
52-week low 329.03
50-day moving average 335.07
200-day moving average 339.55

Share statistics

Avg vol (3-month) 3790.88k
Avg vol (10-day) 3679.57k
Shares outstanding 564M
Implied shares outstanding 664M
Float 826.71M
% held by insiders 160.46%
% held by institutions 13.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 41.64%
Trailing annual dividend rate 30.75
Trailing annual dividend yield 32.05%
5-year average dividend yield 4N/A
Payout ratio 424.19%
Dividend date 3N/A
Ex-dividend date 416 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.22%
Operating margin (ttm)21.30%

Management effectiveness

Return on assets (ttm)5.70%
Return on equity (ttm)10.55%

Income statement

Revenue (ttm)827.93M
Revenue per share (ttm)12.90
Quarterly revenue growth (yoy)-18.70%
Gross profit (ttm)N/A
EBITDA 193.5M
Net income avi to common (ttm)159.13M
Diluted EPS (ttm)2.48
Quarterly earnings growth (yoy)-22.20%

Balance sheet

Total cash (mrq)1.09B
Total cash per share (mrq)17.04
Total debt (mrq)1.79M
Total debt/equity (mrq)0.12%
Current ratio (mrq)7.51
Book value per share (mrq)24.20

Cash flow statement

Operating cash flow (ttm)210.36M
Levered free cash flow (ttm)64.69M